Exceptional anticancer photodynamic properties of [1,4-Bis(3,6,9,12-Tetraoxatridec-1-yloxy)phthalocyaninato]zinc(II)

Christophe Nguyen,Isabelle Toubia,Kamel Hadj-Kaddour,Lamiaa M A Ali,Laure Lichon,Charlotte Cure,Stéphane Diring,Marwan Kobeissi,Fabrice Odobel,Magali Gary-Bobo,Lamiaa M.A. Ali
DOI: https://doi.org/10.1016/j.jphotobiol.2024.112863
2024-02-01
Abstract:Phthalocyanines have been described as effective photosensitizers for photodynamic therapy and are therefore, being studied for their biomedical applications. The metalation of photosensitizers can improve their photodynamic therapy potential. Here, we focus on the biological properties of [1,4-Bis(3,6,9,12-Tetraoxatridec-1-yloxy)phthalocyaninato]zinc(II) (ZnPc(αEG<sub>4</sub>)<sub>2</sub>) and demonstrate its exceptional anticancer activity upon light stimulation to kill preferentially cancer cells with a start of efficiency at 10 pM. Indeed, in this work we highlighted the high selectivity of ZnPc(αEG<sub>4</sub>)<sub>2</sub> for cancer cells compared with healthy ones and we establish its mechanism of action, enabling us to conclude that ZnPc(αEG<sub>4</sub>)<sub>2</sub> could be a powerful tool for cancer therapy.
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?